APOTHEEK INNESTO: what changed
What changed
APOTHEEK INNESTO
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€3,765
2024 · €46,677-€42,912
Equity
€61,478
2024 · €57,713+€3,765
Cash
€73,386
2024 · €23,698+€49,687
Balance sheet total
€545,442
2024 · €486,008+€59,435
Largest movements
Assets
- Cash +€49,687
up €49,687 (+210%), from €23,698 to €73,386
mainly Trade debts (+€48,023) and Depreciation (+€21,171)
- Receivables within one year +€14,973
up €14,973 (+14.9%), from €100,297 to €115,269
of which Trade receivables: +€13,078
- Stocks and contracts -€6,453
down €6,453 (-2.1%), from €309,415 to €302,962
Equity and liabilities
- Trade debts +€48,023
up €48,023 (+42.6%), from €112,647 to €160,671
- Tax, wage and social debts +€8,954
up €8,954 (+56.5%), from €15,846 to €24,800
of which Remuneration and social security: +€6,455
Income statement
- Staff costs +€60,304
up €60,304 (+60.0%), from €100,583 to €160,887
- Gross operating margin +€19,402
up €19,402 (+10.8%), from €179,106 to €198,508
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€46,677
Gross operating margin
+€19,402
Staff costs
-€60,304
Depreciation
-€1,532
Other operating charges
-€1,684
Financial income
+€1,105
Financial charges
-€153
Taxes
+€255
Result 2025
€3,765
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€75,143
Investment
-€22,306
Financing
-€3,150
Cash 2024
€23,698
From operations (derived)
+€75,143
Net result for the year
+€3,765
Depreciation
+€21,171
Stocks and contracts
+€6,453
Receivables within one year
-€14,973
Deferred charges and accrued income
-€94
Trade debts
+€48,023
Tax, wage and social debts
+€8,954
Other debts
+€200
Accrued charges and deferred income
+€1,641
Investment (derived)
-€22,306
Investment in fixed assets (net)
-€22,306
Financing
-€3,150
Current portion of long-term debt
-€3,150
Cash 2025
€73,386
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €486,008 | €545,442 | +€59,435 | +12.2% |
| Fixed assets | 21/28 | €50,785 | €51,919 | +€1,135 | +2.2% |
| Tangible fixed assets | 22/27 | €50,785 | €51,919 | +€1,135 | +2.2% |
| Plant, machinery and equipment | 23 | - | €7,386 | +€7,386 | |
| Furniture and vehicles | 24 | - | €8,728 | +€8,728 | |
| Other tangible fixed assets | 26 | €50,785 | €35,805 | -€14,979 | -29.5% |
| Current assets | 29/58 | €435,223 | €493,523 | +€58,300 | +13.4% |
| Stocks and contracts in progress | 3 | €309,415 | €302,962 | -€6,453 | -2.1% |
| Stocks | 30/36 | €309,415 | €302,962 | -€6,453 | -2.1% |
| Amounts receivable within one year | 40/41 | €100,297 | €115,269 | +€14,973 | +14.9% |
| Trade receivables | 40 | €97,597 | €110,675 | +€13,078 | +13.4% |
| Other amounts receivable | 41 | €2,700 | €4,594 | +€1,894 | +70.2% |
| Cash at bank and in hand | 54/58 | €23,698 | €73,386 | +€49,687 | +210% |
| Deferred charges and accrued income | 490/1 | €1,813 | €1,906 | +€94 | +5.2% |
| Total equity and liabilities | 10/49 | €486,008 | €545,442 | +€59,435 | +12.2% |
| Equity | 10/15 | €57,713 | €61,478 | +€3,765 | +6.5% |
| Contributions | 10/11 | €75,000 | €75,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€17,287 | -€13,522 | +€3,765 | +21.8% |
| Amounts payable | 17/49 | €428,295 | €483,964 | +€55,670 | +13.0% |
| Amounts payable within one year | 42/48 | €427,900 | €481,928 | +€54,028 | +12.6% |
| Current portion of amounts payable after more than one year | 42 | €3,150 | - | -€3,150 | |
| Trade debts | 44 | €112,647 | €160,671 | +€48,023 | +42.6% |
| Suppliers | 440/4 | €112,647 | €160,671 | +€48,023 | +42.6% |
| Taxes, remuneration and social security | 45 | €15,846 | €24,800 | +€8,954 | +56.5% |
| Taxes | 450/3 | €2,721 | €5,221 | +€2,500 | +91.9% |
| Remuneration and social security | 454/9 | €13,125 | €19,579 | +€6,455 | +49.2% |
| Other amounts payable | 47/48 | €296,257 | €296,457 | +€200 | +0.1% |
| Accrued charges and deferred income | 492/3 | €395 | €2,036 | +€1,641 | +416% |
| Remuneration, social security and pensions | 62 | €100,583 | €160,887 | +€60,304 | +60.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €19,639 | €21,171 | +€1,532 | +7.8% |
| Other operating charges | 640/8 | €5,846 | €7,530 | +€1,684 | +28.8% |
| Gross operating margin | 9900 | €179,106 | €198,508 | +€19,402 | +10.8% |
| Operating profit (loss) | 9901 | €53,038 | €8,919 | -€44,119 | -83.2% |
| Financial income | 75/76B | €272 | €1,377 | +€1,105 | +406% |
| Recurring financial income | 75 | €272 | €1,377 | +€1,105 | +406% |
| Financial charges | 65/66B | €3,911 | €4,064 | +€153 | +3.9% |
| Recurring financial charges | 65 | €3,911 | €4,064 | +€153 | +3.9% |
| Profit (loss) for the period before taxes | 9903 | €49,399 | €6,232 | -€43,167 | -87.4% |
| Income taxes | 67/77 | €2,721 | €2,467 | -€255 | -9.4% |
| Profit (loss) for the period | 9904 | €46,677 | €3,765 | -€42,912 | -91.9% |
| Profit (loss) for the period to be appropriated | 9905 | €46,677 | €3,765 | -€42,912 | -91.9% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.